SubscribeLogin
Bill Blair image

News from Bill Blair

Stay current with all the latest and breaking news about Bill Blair, compare headlines and perspectives between news sources on stories happening today. In total, 111 stories have been published about Bill Blair which Ground News has aggregated in the past 3 months.

Media Bias Breakdown

How is the media covering Bill Blair?

Bill Blair often is covered by Center Media sources.
Left: 28%
Center: 53%
19%
Covered Most by:
tickerreport.comUnknown11 recent storiesETF Daily NewsUnknown7 recent storieswkrb13.comUnknown7 recent storiesCollingwood TodayUnknown6 recent stories

Covered Most By

tickerreport.com
tickerreport.com
Unknown
ETF Daily News
ETF Daily News
Unknown
wkrb13.com
wkrb13.com
Unknown
Suggest a source

Top Bill Blair News

EOG Resources (EOG) Q3 2024 Earnings Call Transcript @themotleyfool #stocks $EOG
CFO

EOG Resources (EOG) Q3 2024 Earnings Call Transcript @themotleyfool #stocks $EOG

Coverage: 2 sources
EOG earnings call for the period ending September 30, 2024.See the Story
William Blair Reaffirms “Market Perform” Rating for FibroGen (NASDAQ:FGEN)
Bill Blair

William Blair Reaffirms “Market Perform” Rating for FibroGen (NASDAQ:FGEN)

William Blair reiterated their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report issued on Wednesday,RTT News reports. Separately, StockNews.com began coverage on shares of FibroGen in a research report on Wednesday, November 6th. They set a “hold” rating on the stock. Check Out Our Latest Stock Analysis on FGEN […]See the Story
OptimizeRx (NASDAQ:OPRX) Earns Outperform Rating from William Blair
Bill Blair · United States

OptimizeRx (NASDAQ:OPRX) Earns Outperform Rating from William Blair

OptimizeRx (NASDAQ:OPRX – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other equities research analysts also recently issued reports on the stock. Royal Bank of Canada lowered their price target on shares of OptimizeRx from $14.00 […]See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal